This grant is for developing a crucial research resource within the Accelerating Medicines Partnership in Parkinson’s Disease (AMP PD). It seeks applicants proficient in isolating and sequencing RNA from brain-derived extracellular vesicles. The selected researchers will utilize approximately 2400 blood samples sourced from existing Parkinson’s disease and normal control cohorts, which already possess publicly available longitudinal clinical and sequencing data. The primary objective is to establish a valuable resource that will be integrated into the AMP PD Knowledge Platform, ensuring its wide dissemination and accessibility to the broader scientific community for further research and discovery in Parkinson’s disease.
Opportunity ID: 341994
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-NS-23-014 |
| Funding Opportunity Title: | Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 – Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 08, 2022 |
| Last Updated Date: | Jul 08, 2022 |
| Original Closing Date for Applications: | Sep 19, 2022 |
| Current Closing Date for Applications: | Sep 19, 2022 |
| Archive Date: | Oct 25, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This funding opportunity announcement (FOA) seeks applicants experienced in the isolation and sequencing of RNA from brain-derived extracellular vesicles to develop a research resource for the Accelerating Medicines Partnership in Parkinson’s Disease (AMP PD). Approximately 2400 blood samples will be provided for this project from existing Parkinson’s disease and normal control cohorts that already have longitudinal clinical and sequencing data that is publicly available to interested researchers. It is intended that this resource will become a part of the AMP PD Knowledge Platform, where it will be broadly shared with the research community. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-014.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00275647 | Aug 19, 2022 | Sep 19, 2022 | View |
Package 1
Mandatory forms
341994 RR_SF424_5_0-5.0.pdf
341994 PHS398_CoverPageSupplement_5_0-5.0.pdf
341994 RR_OtherProjectInfo_1_4-1.4.pdf
341994 PerformanceSite_4_0-4.0.pdf
341994 RR_KeyPersonExpanded_4_0-4.0.pdf
341994 RR_Budget_3_0-3.0.pdf
341994 PHS398_ResearchPlan_4_0-4.0.pdf
341994 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
341994 RR_SubawardBudget30_3_0-3.0.pdf
341994 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
